Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 163,240 | 210,631 | 164,573 | 123,231 | 142,837 |
| Marketable Securities | 320,029 | 298,451 | 145,017 | 215,642 | 309,903 |
| Receivables | 46,923 | 44,828 | 43,040 | 40,555 | 33,284 |
| Inventories | 19,556 | 15,767 | 12,979 | 12,831 | 14,041 |
| TOTAL | $579,469 | $585,277 | $383,884 | $407,949 | $520,073 |
| Non-Current Assets | |||||
| PPE Net | 43,863 | 44,618 | 46,945 | 47,688 | 47,705 |
| Intangibles | 197,797 | 197,797 | 197,797 | 197,797 | 197,797 |
| Other Non-Current Assets | 65,391 | 72,850 | 72,825 | 84,915 | 84,632 |
| TOTAL | $307,051 | $315,265 | $317,567 | $330,400 | $330,134 |
| Total Assets | $886,520 | $900,542 | $701,451 | $738,349 | $850,207 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 25,963 | 14,764 | 14,306 | 16,239 | 21,722 |
| Accrued Expenses | 96,841 | 89,595 | 85,478 | 66,722 | 99,901 |
| Other current liabilities | N/A | N/A | N/A | 1,250 | N/A |
| TOTAL | $129,676 | $111,727 | $108,300 | $91,714 | $128,812 |
| Non-Current Liabilities | |||||
| Long Term Debt | 389,254 | 388,584 | 147,834 | 147,569 | 149,505 |
| Other Non-Current Liabilities | 68,908 | 66,005 | 70,407 | 82,515 | 81,508 |
| TOTAL | $470,464 | $468,546 | $232,198 | $244,041 | $244,970 |
| Total Liabilities | $600,140 | $580,273 | $340,498 | $335,755 | $373,782 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 264,316 | 260,588 | 258,788 | 257,664 | 257,245 |
| Common Shares | 2,650 | 2,626 | 2,614 | 2,607 | 2,598 |
| Retained earnings | -2,045,462 | -1,974,061 | -1,910,050 | -1,857,558 | -1,768,610 |
| Other shareholders' equity | 20,614 | 16,907 | 17,540 | 19,199 | 15,212 |
| TOTAL | $286,380 | $320,269 | $360,953 | $402,594 | $476,425 |
| Total Liabilities And Equity | $886,520 | $900,542 | $701,451 | $738,349 | $850,207 |